Issue 6/2021
Content (32 Articles)
Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review
Kamel Laribi, Mohamad Sobh, David Ghez, Alix Baugier de Materre
What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?
Steffen T. Simon, Anne Pralong, Michael Hallek, Christoph Scheid, Udo Holtick, Marco Herling
Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Xiaoyin Bu, Jinman Zhong, Weiru Li, Shengchun Cai, Ya Gao, Baohong Ping
Neutrophil gelatinase–associated lipocalin as a biomarker of nephropathy in sickle cell disease
Rajaa Marouf, Adekunle D. Adekile, Hadeel El-Muzaini, Rasha Abdulla, Olusegun A. Mojiminiyi
Frequency of bacteremia in patients with sickle cell disease: a longitudinal study
Jaffar A. Al-Tawfiq, Ali A. Rabaan, Mohammed H. AlEdreesi
Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients
Dinesh Bhurani, Jyotsna Kapoor, Neha Yadav, Vishvdeep Khushoo, Narendra Agrawal, Rayaz Ahmed, Jatinder Singh Arora, Pallavi Mehta
Presentation of two new mutations in the 3′untranslated region of the β-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey
Abdullah Arpaci, Bahar Unlu Gul, Oguzhan Ozcan, Gul Ilhan, Cigdem El, Emre Dirican, Sibel Elmacioglu, Hasan Kaya
Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients
Jacqueline S. González, María Agustina Perusini, Ana L. Basquiera, Graciela Alfonso, Dorotea Fantl, Walter Macedo Lima, Elsa Nucifora, Carolina Lazzarino, Viviana Novoa, Marcela Cavalcanti de Andrade Silva, Irene B. Larripa, Vanderson Rocha, Jorge Arbelbide, Elvira D. R. P. Velloso, Carolina B. Belli
Stanozolol for the treatment of anemic lower-risk myelodysplastic syndromes without del(5q) after failure of epoetin alfa: findings from a retrospective study
Wei-ying Qu, Lin Zhao, Xv-cheng Tan, Yi-han Zhao
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)
Anna Hecht, Julia A. Meyer, Johann-Christoph Jann, Katja Sockel, Aristoteles Giagounidis, Katharina S. Götze, Anne Letsch, Detlef Haase, Richard F. Schlenk, Torsten Haferlach, Philippe Schafhausen, Gesine Bug, Michael Lübbert, Felicitas Thol, Guntram Büsche, Esther Schuler, Verena Nowak, Julia Obländer, Stephanie Fey, Nadine Müller, Georgia Metzgeroth, Wolf-Karsten Hofmann, Ulrich Germing, Florian Nolte, Mark Reinwald, Daniel Nowak
Tissue factor–bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study
Hongli Zhao, Jiayue Sun, Liru Yan, Bo Jin, Wenyi Hou, Fenglin Cao, Haitao Li, Jin Zhou, Yingmei Zhang
High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cells
Zhihong Zeng, Charlie Ly, Naval Daver, Jorge Cortes, Hagop M. Kantarjian, Michael Andreeff, Marina Konopleva
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
María P. Martínez Sánchez, Juan Eduardo Megías-Vericat, Rebeca Rodríguez-Veiga, Susana Vives, Juan Miguel Bergua, Anna Torrent, Sara Suárez-Varela, Blanca Boluda, Joaquín Martínez-López, Isabel Cano-Ferri, Evelyn Acuña-Cruz, Laura Torres-Miñana, Beatriz Martín-Herreros, Alfons Serrano, Amparo Sempere, Eva Barragán, Claudia Sargas, Miguel Sanz, David Martínez-Cuadrón, Pau Montesinos
Ibrutinib combined with venetoclax for the treatment of relapsed/refractory diffuse large B cell lymphoma
Zhiyuan Zhou, Lei Zhang, Xinhua Wang, Xin Li, Ling Li, Xiaorui Fu, Xudong Zhang, Zhaoming Li, Zhenchang Sun, Mingzhi Zhang
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience
Sandra Bašić-Kinda, Ivo Radman, Dino Dujmović, Ivana Ilić, Marko Kralik, Margareta Dobrenić, Lea Galunić-Bilić, Pavle Rončević, Marijo Vodanović, Zrinka Sertić, Ida Hude, Igor Aurer
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial
M. Picardi, C. Cavaliere, R. Della Pepa, E. Nicolai, A. Soricelli, C. Giordano, N. Pugliese, M.G. Rascato, I. Cappuccio, G. Campagna, C. Cerchione, E. Vigliar, G. Troncone, M. Mascolo, M. Franzese, R. Castaldo, M. Salvatore, F. Pane
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns
Sophia Danhof, Leo Rasche, Anja Mottok, Tabea Steinmüller, Xiang Zhou, Martin Schreder, Teresa Kilian, Susanne Strifler, Andreas Rosenwald, Michael Hudecek, Hermann Einsele, Elena Gerhard-Hartmann
Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone
Qian-qian Cai, Xue-min Gao, Jing Le, Hao Zhao, Hao Cai, Xin-xin Cao, Jian Li
Long-term outcome after allogeneic stem cell transplantation in multiple myeloma
Sini Luoma, Raija Silvennoinen, Auvo Rauhala, Riitta Niittyvuopio, Eeva Martelin, Vesa Lindström, Jouni Heiskanen, Liisa Volin, Tapani Ruutu, Anne Nihtinen
Allogeneic stem cell transplantation for mantle cell lymphoma—update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74)
William H. Krüger, Carsten Hirt, Nadezda Basara, Herbert G. Sayer, Gerhard Behre, Thomas Fischer, Norbert Grobe, Georg Maschmeyer, Thomas Neumann, Laila Schneidewind, Dietger Niederwieser, Gottfried Dölken, Christian A. Schmidt
Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study
Yue Lu, Yan-Li Zhao, Jian-Ping Zhang, Min Xiong, Xing-Yu Cao, De-Yan Liu, Rui-Juan Sun, Zhi-Jie Wei, Jia-Rui Zhou, Dao-Pei Lu
Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis
Sarah Weber, Aaron Magh, Michael Hogardt, Volkhard A. J. Kempf, Maria J. G. T. Vehreschild, Hubert Serve, Sebastian Scheich, Björn Steffen
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
Annika Y. Classen, Larissa Henze, Marie von Lilienfeld-Toal, Georg Maschmeyer, Michael Sandherr, Luisa Durán Graeff, Nael Alakel, Maximilian Christopeit, Stefan W. Krause, Karin Mayer, Silke Neumann, Oliver A. Cornely, Olaf Penack, Florian Weißinger, Hans-Heinrich Wolf, Jörg Janne Vehreschild
A case of transplantation-associated thrombotic microangiopathy with autopsy-proven fatal myocardial ischemia after allogeneic hematopoietic stem cell transplantation
Ken Sasaki, Akira Honda, Aya Shinozaki-Ushiku, Yosei Fujioka, Hiroaki Maki, Kazuhiro Toyama, Tetsuo Ushiku, Mineo Kurokawa
Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone
Ivan Krečak, Ivana Ruščić, Josipa Jović Zlatović, Marijana Šupe, Marija Valovičić Krečak, Velka Gverić-Krečak
Paroxysmal nocturnal haemoglobinuria associated with a novel phosphatidylinositol glycan class A (PIGA) mutation in a patient with Klinefelter syndrome
Yotaro Tamai, Sayaka Ito, Atsuhiko Hasegawa
Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant
Amany R. Keruakous, Pragathi Balakrishna, Sarah A. Schmidt, Marcus T. Autry, Adam Asch
Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677”
Marco Picardi, Claudia Giordano, Roberta Della Pepa, Novella Pugliese, Aldo Leone, Giuseppe Gentile, Fabrizio Pane
Very rare lineage switch from acute myeloid leukemia with BCR-ABL1 to B-lymphoblastic leukemia
Ting Li, Hongwei Chen, Yun Zhang, Yuxiao Zeng, Liheng Zheng
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
Khalid Shoumariyeh, Johannes Jung, Michael Rassner, Sandra Maria Dold, Veronika Riebl, Milena Pantic, Georg Herget, Reinhard Marks, Michael Lübbert, Ralph Wäsch, Monika Engelhardt
Multifocal osteolytic lesions in hairy cell leukemia—the importance of PET/CT in diagnosis and assessment
Pawel Robak, Dorota Jesionek-Kupnicka, Piotr Kupnicki, Aaron Polliack, Tadeusz Robak